Suppr超能文献

一项评估射频消融术与手术治疗骨样骨瘤的疗效和安全性的对比研究:单机构回顾性分析

A comparative study assessing the efficacy and safety of radiofrequency ablation versus surgical treatment for osteoid osteoma: retrospective analysis in a single institution.

作者信息

Igrec Jasminka, Smolle Maria Anna, Meszarics Michael, Godschachner Theresa Marie, Steiner Jakob, Feichtinger Mira, Talakic Emina, Portugaller Rupert Horst, Leithner Andreas, Fuchsjäger Michael, Brcic Iva

机构信息

Division of General Radiology, Department of Radiology, Medical University of Graz, Graz, Austria.

Department of Orthopaedics and Traumatology, Medical University of Graz, Graz, Austria.

出版信息

Insights Imaging. 2024 Mar 22;15(1):82. doi: 10.1186/s13244-024-01656-1.

Abstract

OBJECTIVE

We aim to evaluate the efficacy of CT-guided percutaneous radiofrequency ablation (RFA) and surgical treatment in osteoid osteoma (OO) treated at the Medical University of Graz.

MATERIALS AND METHODS

In a single-institution study, we analysed data from January 2005 to January 2021 of patients with histological/radiological diagnosis of OO. CT and MRI scans were reviewed for typical findings. Means (with SD) and medians (with IQR) were reported for normally and non-normally distributed variables. Differences between groups were assessed using chi-squared tests and t-tests.

RESULTS

One hundred nineteen patients (mean age: 21.6 ± 10.9 years; 63.9% males) with confirmed OO were retrospectively evaluated. 73 and 43 patients underwent RFA and surgery, respectively. In three cases, RFA combined with surgery was performed. Pre-intervention, 103 patients (88.8%) had undergone CT, and 101 had an MRI (87.1%). The nidus was confirmed in 82.5% of cases with CTs (85/103) and 63.4% with MRIs (64/101). The majority of nidi were located cortically (n = 96; 82.8%), most frequently in the femur (38 patients, 33.3%) with a median size of 8.0 mm (IQR: 5.0-12.0 mm). Median symptom duration before treatment was 6.0 (IQR: 4.0-13.0) months. The complication rate was 12.1% (14/116; 15.1% RFA vs. 7.0% surgery; p = 0.196). In total, 11.2% of patients had persistent symptoms after one week with clinical success rates of RFA and surgery, 86.3% and 90.7% (p = 0.647), respectively.

CONCLUSION

Compared to surgical treatment, CT-guided percutaneous RFA is a safe, minimally invasive, reliable, and efficient treatment option for OO.

CRITICAL RELEVANCE STATEMENT

This article critically assesses the diagnosis and treatment of osteoid osteoma, emphasising accurate imaging, and detailing a non-invasive option for effective management.

KEY POINTS

• This study analyses 116 cases of OO at one institution, focusing on symptom persistence, recurrence in short-term follow-up, and complications in two study groups. • Surgery showed higher, though not statistically significant, success despite comparable symptom persistence; CT displayed typical OO features more than MRI, regardless of the intramedullary, cortical and subperiosteal location as well as the site of the affected bone. • CT-guided RFA is an effective therapeutic alternative for OO compared to surgical intervention. In case of atypical OO appearance, RFA is not the first-line treatment.

摘要

目的

我们旨在评估在格拉茨医科大学接受治疗的骨样骨瘤(OO)患者中,CT引导下经皮射频消融(RFA)和手术)和手术治疗的疗效。

材料与方法

在一项单机构研究中,我们分析了2005年1月至2021年1月间经组织学/放射学诊断为骨样骨瘤患者的数据。回顾CT和MRI扫描结果以寻找典型表现。对于正态分布和非正态分布变量,分别报告均值(及标准差)和中位数(及四分位数间距)。使用卡方检验和t检验评估组间差异。

结果

对119例确诊为骨样骨瘤的患者(平均年龄:21.6±10.9岁;63.9%为男性)进行了回顾性评估。分别有73例和43例患者接受了RFA和手术治疗。3例患者接受了RFA联合手术治疗。干预前,103例患者(88.8%)接受了CT检查,101例患者(87.1%)接受了MRI检查。CT检查确诊瘤巢的病例占82.5%(85/103),MRI检查确诊瘤巢的病例占63.4%(64/101)。大多数瘤巢位于皮质(n = 96;82.8%),最常见于股骨(38例患者,33.3%),瘤巢中位大小为8.0mm(四分位数间距:5.0 - 12.0mm)。治疗前症状持续时间的中位数为6.0(四分位数间距:4.0 - 13.0)个月。并发症发生率为12.1%(14/116;RFA组为15.1%,手术组为7.0%;p = 0.196)。总体而言,11.2%的患者在一周后仍有持续症状,RFA组和手术组的临床成功率分别为86.3%和90.7%(p = 0.647)。

结论

与手术治疗相比,CT引导下经皮RFA是一种安全、微创、可靠且有效的骨样骨瘤治疗选择。

关键相关性声明

本文对骨样骨瘤的诊断和治疗进行了批判性评估,强调了准确成像,并详细介绍了一种有效的非侵入性管理选择。

要点

• 本研究分析了一家机构的116例骨样骨瘤病例,重点关注症状持续情况、短期随访中的复发情况以及两个研究组中的并发症情况。• 尽管症状持续情况相当,但手术显示出更高的成功率,虽无统计学意义;无论瘤巢位于髓内、皮质还是骨膜下以及受累骨的部位,CT比MRI更能显示典型骨样骨瘤特征。• 与手术干预相比,CT引导下RFA是骨样骨瘤的一种有效治疗替代方法。对于非典型骨样骨瘤表现,RFA不是一线治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34b9/10959911/9b77224ea9fd/13244_2024_1656_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验